Next deadline for Bioinnovation Institute´s Creation House program is 23rd of February

Jan 11, 2021

MVA-member, BioInnovation Institute´s, 18-months Creation House Program is for companies with a solid, initial business plan aiming to build a case that can attract substantial funding. In the therapeutic area, a cellular proof of concept with chemical or biological tool compounds is required. In bioindustrials, a proof of concept on MVP is required and in health tech, a scale-up ready MVP is required.

In collaboration with the BII team and their network of experts, you will make a gap-analysis for your start-up to find weak spots and roll out a development plan with every little step needed to reach the milestones on drug development, good manufacturing practice, regulatory strategy et cetera.  BII will fund up to seven companies in the program with a risk-free convertible loan of EUR 1.3M.

Learn how to apply on the link above and make sure to read the guidelines for applicants

Most recent news